Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 518† | — | 271† | 239† | 232† |
| Net profit | 76 | 49 | 24 | 20† | 20† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Ankit Kedarmal Bankda | Executive Director | June 30, 2026 |
| Kedarmal Shankarlal Bankda | Executive Director | June 30, 2026 |
| Vijay Shankarlal Bankda | Executive Director | June 30, 2026 |
| Ankit Jain | Independent Director | June 30, 2026 |
| Ritesh Kumar Lunkad | Independent Director | June 30, 2026 |
| Ruchi Jindal | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
